Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Blood|January 25, 2005
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosisAlessandro M Vannucchi, Lucia Bianchi, Francesco Paoletti, et al.
Haematologica|December 22, 2010
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3Tiziano Barbui, Alessandra Carobbio, Guido Finazzi, et al.
Blood|June 25, 2009
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allelePaola Guglielmelli, Giovanni Barosi, Giorgina Specchia, et al.
The New Microbiologica|July 18, 2024
Hepatitis C Virus (HCV) genotypes distribution in South-Eastern Tuscany: a ten-year retrospective studyAgostino Ognibene, Giulio Camarlinghi, Maria Lorubbio, et al.
Drug Design, Development and Therapy|June 2, 2015
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating studyNicola Cascavilla, Valerio De Stefano, Fabrizio Pane, et al.
Journal of Clinical Medicine|February 26, 2025
New Diseases Related to Cardiac Implantable Electronic Devices (CIEDs): An OverviewPasquale Crea, Federica Cocuzza, Salvatore Bonanno, et al.
Oncotarget|April 15, 2015
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicityDavide Valente, Gianluca Bossi, Alice Moncada, et al.
Blood Advances|January 4, 2018
Targeted deep sequencing in polycythemia vera and essential thrombocythemiaAyalew Tefferi, Terra L Lasho, Paola Guglielmelli, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Pageof 5